📰 Extended Release News
Extended Release News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Extended Release. Real-time updates on events, politics, business and more.
March 28, 2024
Investor Presentation | March 2024 Disclaimer Ensysces PF614 and nafamostat are currently in clinical trial and pre-clinical studies,...
September 13, 2023
/PRNewswire/ -- The report "Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and...
June 6, 2023
Deca Durabolin, known as nandrolone decanoate, is an intriguing compound that has captivated the world of fitness and bodybuilding.
April 10, 2023
According to a market research study published by Zion Market Research, Global Pharmaceutical Solid Dosage Contract Manufacturing Market size & share...
December 1, 2022
In 2022, the understanding of people of the best way to take Phentermine 37.5 to achieve the greatest outcomes has been regarded as a serious matter by medical professionals who believe that using phentermine incorrectly could be fatal and might not result in successful weight loss. Many people around the world use Phentermine diet pills to weight loss strategy, however many
April 27, 2022
Sanofi has offloaded the French rights to a prolonged-release and divisible tablet formulations of lithium carbonate to Laboratoires Delbert, a company focused on the revival of essential medicines.
March 23, 2022
(RTTNews) - Sandoz Inc., a generic and biosimilar medicines unit of French drug major Novartis, is recalling 13 lots of oral pain management drug ...
March 23, 2022
The voluntary recall of Orphenadrine Citrate 100 mg Extended Release Tablets by Sandoz involves 13 lots of the drug that were shipped to consumers from August 2019 to April 2021.
January 27, 2022
Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a devastating necrotizing skin disease. Key to its pathogenesis is mycolactone, the exotoxin virulence factor that is both immunosuppressive and cytotoxic. The discovery that the essential Sec61 translocon is the major cellular target of mycolactone explains much of the disease pathology, including the immune blockade. Sec61 inhibition leads to a loss in production of nearly all cytokines from monocytes, macrophages, dendritic cells and T c...